Ozkalayci H, Menguc M, Lafci N, Ozturk Kaymak A
Turk J Haematol. 2023; 40(4):288-290.
PMID: 37698253
PMC: 10701324.
DOI: 10.4274/tjh.galenos.2023.2023.0270.
Eren F, Yozgat A, Firat Oguz E, Neselioglu S, Firat R, Gurlek Gokcebay D
J Clin Med. 2023; 12(6).
PMID: 36983421
PMC: 10052047.
DOI: 10.3390/jcm12062422.
Neselioglu S, Firat Oguz E, Erel O
Antioxidants (Basel). 2022; 11(11).
PMID: 36358559
PMC: 9686494.
DOI: 10.3390/antiox11112187.
Focarelli F, Giachino A, Waldron K
PLoS Pathog. 2022; 18(7):e1010617.
PMID: 35862345
PMC: 9302775.
DOI: 10.1371/journal.ppat.1010617.
Lazar-Poloczek E, Romuk E, Rozentryt P, Duda S, Gasior M, Wojciechowska C
Int J Mol Sci. 2021; 22(18).
PMID: 34576235
PMC: 8467566.
DOI: 10.3390/ijms221810074.
Genetic Regulation of Biomarkers as Stress Proxies in Dairy Cows.
Milanesi M, Passamonti M, Cappelli K, Minuti A, Palombo V, Sgorlon S
Genes (Basel). 2021; 12(4).
PMID: 33917627
PMC: 8067459.
DOI: 10.3390/genes12040534.
Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients.
Romuk E, Jachec W, Zbrojkiewicz E, Mroczek A, Niedziela J, Gasior M
J Clin Med. 2020; 9(1).
PMID: 31947878
PMC: 7019681.
DOI: 10.3390/jcm9010137.
6-Hydroxydopamine: a far from simple neurotoxin.
Vareslija D, Tipton K, Davey G, McDonald A
J Neural Transm (Vienna). 2020; 127(2):213-230.
PMID: 31894418
DOI: 10.1007/s00702-019-02133-6.
Does Ceruloplasmin Defend Against Neurodegenerative Diseases?.
Wang B, Wang X
Curr Neuropharmacol. 2018; 17(6):539-549.
PMID: 29737252
PMC: 6712297.
DOI: 10.2174/1570159X16666180508113025.
Possible Effects of Copper and Ceruloplasmin Levels on Auditory Event Potentials in Boys with Attention Deficit Hyperactivity Disorder.
Yorbik O, Mutlu C, Ozdag M, Olgun A, Eryilmaz G, Ayta S
Noro Psikiyatr Ars. 2017; 53(4):321-327.
PMID: 28360806
PMC: 5353038.
DOI: 10.5152/npa.2016.12659.
Determination of ceruloplasmin, some other acute phase proteins, and biochemical parameters in cows with endometritis.
Kaya S, Merhan O, Kacar C, Colak A, Bozukluhan K
Vet World. 2016; 9(10):1056-1062.
PMID: 27847413
PMC: 5104712.
DOI: 10.14202/vetworld.2016.1056-1062.
Ceruloplasmin-ferroportin system of iron traffic in vertebrates.
Musci G, Polticelli F, Bonaccorsi di Patti M
World J Biol Chem. 2014; 5(2):204-15.
PMID: 24921009
PMC: 4050113.
DOI: 10.4331/wjbc.v5.i2.204.
Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity.
Hineno A, Kaneko K, Yoshida K, Ikeda S
Neurochem Res. 2011; 36(11):2127-35.
PMID: 21706374
PMC: 3183265.
DOI: 10.1007/s11064-011-0537-8.
Physiological stress and innate immune response in gilthead sea bream (Sparus aurata) and sea bass (Dicentrarchus labrax) exposed to combination of trimethoprim and sulfamethoxazole (TMP-SMX).
Yildiz H, Altunay S
Fish Physiol Biochem. 2010; 37(3):401-9.
PMID: 20924669
DOI: 10.1007/s10695-010-9440-5.
mRNA expression of proteins involved in iron homeostasis in brain regions is altered by age and by iron overloading in the neonatal period.
Dornelles A, Garcia V, de Lima M, Vedana G, Alcalde L, Bogo M
Neurochem Res. 2009; 35(4):564-71.
PMID: 19943190
DOI: 10.1007/s11064-009-0100-z.
Metals in the "omics" world: copper homeostasis and cytochrome c oxidase assembly in a new light.
Bertini I, Cavallaro G
J Biol Inorg Chem. 2007; 13(1):3-14.
PMID: 17987327
DOI: 10.1007/s00775-007-0316-9.
Iron in chronic brain disorders: imaging and neurotherapeutic implications.
Stankiewicz J, Panter S, Neema M, Arora A, Batt C, Bakshi R
Neurotherapeutics. 2007; 4(3):371-86.
PMID: 17599703
PMC: 1963417.
DOI: 10.1016/j.nurt.2007.05.006.
Ceruloplasmin and what it might do.
Healy J, Tipton K
J Neural Transm (Vienna). 2007; 114(6):777-81.
PMID: 17406962
DOI: 10.1007/s00702-007-0687-7.
Linkage between catecholate siderophores and the multicopper oxidase CueO in Escherichia coli.
Grass G, Thakali K, Klebba P, Thieme D, Muller A, Wildner G
J Bacteriol. 2004; 186(17):5826-33.
PMID: 15317788
PMC: 516812.
DOI: 10.1128/JB.186.17.5826-5833.2004.
Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.
Sung C, Parry T, Riccobene T, Mahoney A, Roschke V, Murray J
AAPS PharmSci. 2002; 4(2):E8.
PMID: 12102617
PMC: 2751295.
DOI: 10.1208/ps040208.